Home   >  
Ion Channel/Membrane Transporter
  • Neuro Signaling Pathway
  • GPCR/G Protein
P2 Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

P2 Receptor

Chemical Structure Cat. No. Product Name CAS No.
Vicagrel Chemical Structure
BCP24464 Vicagrel 1314081-53-2
Vicagrel, an acetate derivative of Clopidogrel, is a P2Y12 platelet inhibitor potentially for the treatment of thrombosis.
GW791343 trihydrochloride Chemical Structure
BCP23425 GW791343 trihydrochloride 309712-55-8
GW791343 3HCl is a HCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.
Uridine-5'-triphosphoric acid trisodium salt Chemical Structure
BCP30809 Uridine-5'-triphosphoric acid trisodium salt 19817-92-6
Uridine 5’-Triphosphate Trisodium Salt is a polyphosphate analogue of uridine that is used in the synthesis of agonists at the G-protein-coupled P2Y receptors.
Uridine-5'-diphosphate disodium salt Chemical Structure
BCP30808 Uridine-5'-diphosphate disodium salt 27821-45-0
UDP disodium salt is an endogenous P2Y receptor agonist which preferentially activates P2Y6.
Clopidogrel Besylate Chemical Structure
BCP13469 Clopidogrel Besylate 744256-69-7
Clopidogrel besylate is a ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION.
Clopidogrel thiolactone Chemical Structure
BCP15749 Clopidogrel thiolactone 1147350-75-1
2-Oxoclopidogrel is a metabolite of Clopidogrel.
Gefapixant Chemical Structure
BCP26079 Gefapixant 1015787-98-0
Gefapixant is an orally active P2X3 receptor (P2X3R) antagonist with IC 50s of ~30 nM versus recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors.
RO-3 Chemical Structure
BCP18267 RO-3 1026582-88-6
RO-3 is a selective P2X3 and P2X2/3 antagonist.
Cangrelor tetrasodium Chemical Structure
BCP15965 Cangrelor tetrasodium 163706-36-3
Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate.
Cangrelor Chemical Structure
BCP07743 Cangrelor 163706-06-7
Cangrelor is a P2Y12 inhibitor used as an antiplatelet drug for intravenous application.
123下一页末页共 33 条记录 1 / 4 页